Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project-Reference-Cited by-同舟云学术

Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project

Published:2013-03 Issue:2 Volume:9 Page:101-106
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Edwards Beatrice J.¹,Usmani Sarah¹,Raisch Dennis W.¹,McKoy June M.¹,Samaras Athena T.¹,Belknap Steven M.¹,Trifilio Steven M.¹,Hahr Allison¹,Bunta Andrew D.¹,Abu-Alfa Ali¹,Langman Craig B.¹,Rosen Steve T.¹,West Dennis P.¹

Affiliation:

1. Northwestern University; Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Northwestern University; Northwestern University Hospital, Chicago, IL; University of New Mexico College of Pharmacy; VA Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM; Yale University School of Medicine, New Haven CT; and American University of Beirut, Beirut, Lebanon

Abstract

Analysis of bisphosphonate-associated acute kidney injury reports for cancer cases within FDA's Adverse Events and Reporting System failed to demonstrate a significant safety signal, an unexpected finding given prior preclinical and clinical findings that suggested a causal association between BPs and AKI.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2011.000486

Reference65 articles.

1. Bisphosphonates: Preclinical Review

2. The Influence of Two Diphosphonates on Calcium Metabolism in the Rat

3. Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line

4. Metastatic bone disease: clinical features, pathophysiology and treatment strategies

5. Cancer statistics, 1998

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma;Critical Reviews in Oncology/Hematology;2024-09

2. Challenges of Renal Function Assessment in Breast Cancer Patients Treated With Abemaciclib: A Case Report;Cureus;2024-08-25

3. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-07-09

4. Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System;JCO Oncology Practice;2024-01

5. Acute tubulusnecrose na zoledronaat voor de behandeling van osteoporose: casusbespreking en literatuurstudie;Tijdschrift voor Geneeskunde;2023-12-15